Squarepoint Ops LLC Anavex Life Sciences Corp. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Squarepoint Ops LLC holds 16,703 shares of AVXL stock, worth $187,574. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,703

Previous 45,352 63.17%

Holding current value

$187,574

Previous $191,000 50.79%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.11 - $7.04 $117,747 - $201,688	-28,649 Reduced 63.17%	16,703 $94,000
Q2 2024 Aug 14, 2024	BUY	$3.39 - $5.02 $153,743 - $227,667	45,352 New	45,352 $191,000
Q4 2023 Feb 14, 2024	BUY	$5.04 - $9.95 $41,378 - $81,689	8,210 Added 54.04%	23,403 $217,000
Q2 2023 Aug 14, 2023	BUY	$7.66 - $9.5 $116,378 - $144,333	15,193 New	15,193 $123,000
Q4 2022 Feb 14, 2023	BUY	$7.65 - $14.43 $13,326 - $25,137	1,742 Added 8.68%	21,810 $201,000
Q3 2022 Nov 14, 2022	BUY	$8.9 - $12.86 $178,605 - $258,074	20,068 New	20,068 $207,000
Q1 2022 May 16, 2022	SELL	$9.74 - $17.69 $126,298 - $229,386	-12,967 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$16.88 - $23.31 $808,568 - $1.12 Million	-47,901 Reduced 78.7%	12,967 $225,000
Q3 2021 Nov 15, 2021	BUY	$16.82 - $25.75 $340,588 - $521,411	20,249 Added 49.85%	60,868 $1.09 Million
Q2 2021 Aug 16, 2021	BUY	$10.16 - $28.86 $51,978 - $147,647	5,116 Added 14.41%	40,619 $929,000
Q1 2021 May 17, 2021	BUY	$5.17 - $16.13 $183,550 - $572,663	35,503 New	35,503 $531,000
Q4 2020 Feb 16, 2021	SELL	$4.01 - $7.58 $225,181 - $425,654	-56,155 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$3.8 - $5.0 $213,389 - $280,775	56,155 New	56,155 $256,000
Q4 2019 Feb 14, 2020	SELL	$2.31 - $3.14 $29,177 - $39,661	-12,631 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$2.22 - $3.9 $28,040 - $49,260	12,631 New	12,631 $40,000
Q1 2018 May 15, 2018	SELL	$2.32 - $3.44 $39,565 - $58,665	-17,054 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$3.12 - $4.94 $53,208 - $84,246	17,054	17,054 $55,000

Others Institutions Holding AVXL

# of Institutions

157

Shares Held

27.4M

Call Options Held

515K

Put Options Held

838K

View Full List

About ANAVEX LIFE SCIENCES CORP.

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $875M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

More about AVXL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Anavex Life Sciences Corp. Transaction History